Publications

Found 4 results
Filters: Author is W.L. Zhang  [Clear All Filters]
2012
Y. Hu, Zhang, W. L., Xie, S. L., Zhao, Y., Hu, J. L., Cai, X. F., Lai, G. Q., and Huang, A. L., An improved reverse dot hybridization for simple and rapid detection of adefovir dipivoxil-resistant hepatitis B virus, vol. 11, pp. 53-60, 2012.
Aloman C and Wands JR (2003). Resistance of HBV to adefovir dipivoxil: a case for combination antiviral therapy? Hepatology 38: 1584-1587. http://dx.doi.org/10.1002/hep.510380633 PMid:14655682 Chan V, Yam I, Chen FE and Chan TK (1999). A reverse dot-blot method for rapid detection of non-deletion alpha thalassaemia. Br. J. Haematol. 104: 513-515. http://dx.doi.org/10.1046/j.1365-2141.1999.01221.x PMid:10086788 Dai CY, Chuang WL, Hsieh MY and Lee LP (2007). Adefovir dipivoxil treatment of lamivudine-resistant chronic hepatitis B. Antiviral Res. 75: 146-151. http://dx.doi.org/10.1016/j.antiviral.2007.02.003 PMid:17400303 Delaney WE (2007). Progress in the treatment of chronic hepatitis B: long-term experience with adefovir dipivoxil. J. Antimicrob. Chemother. 59: 827-832. http://dx.doi.org/10.1093/jac/dkl551 PMid:17332007 Fung SK, Chae HB, Fontana RJ, Conjeevaram H, et al. (2006). Virologic response and resistance to adefovir in patients with chronic hepatitis B. J. Hepatol. 44: 283-290. http://dx.doi.org/10.1016/j.jhep.2005.10.018 PMid:16338024 Hadziyannis SJ, Tassopoulos NC, Heathcote EJ, Chang TT, et al. (2006). Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years. Gastroenterology 131: 1743-1751. http://dx.doi.org/10.1053/j.gastro.2006.09.020 PMid:17087951 Lok AS, Zoulim F, Locarnini S, Bartholomeusz A, et al. (2007). Antiviral drug-resistant HBV: standardization of nomenclature and assays and recommendations for management. Hepatology 46: 254-265. http://dx.doi.org/10.1002/hep.21698 PMid:17596850 Lovicu M, Dessi V, Zappu A, De VS, et al. (2003). Efficient strategy for molecular diagnosis of Wilson disease in the sardinian population. Clin. Chem. 49: 496-498. http://dx.doi.org/10.1373/49.3.496 PMid:12600964 Luan J, Yuan J, Li X, Jin S, et al. (2009). Multiplex detection of 60 hepatitis B virus variants by maldi-tof mass spectrometry. Clin. Chem. 55: 1503-1509. http://dx.doi.org/10.1373/clinchem.2009.124859 PMid:19541863 Moskovitz DN, Osiowy C, Giles E, Tomlinson G, et al. (2005). Response to long-term lamivudine treatment (up to 5 years) in patients with severe chronic hepatitis B, role of genotype and drug resistance. J. Viral. Hepat. 12: 398-404. http://dx.doi.org/10.1111/j.1365-2893.2005.00613.x PMid:15985011 Ohishi W, Shirakawa H, Kawakami Y, Kimura S, et al. (2004). Identification of rare polymerase variants of hepatitis B virus using a two-stage PCR with peptide nucleic acid clamping. J. Med. Virol. 72: 558-565. http://dx.doi.org/10.1002/jmv.20026 PMid:14981758 Osiowy C, Villeneuve JP, Heathcote EJ, Giles E, et al. (2006). Detection of rtN236T and rtA181V/T mutations associated with resistance to adefovir dipivoxil in samples from patients with chronic hepatitis B virus infection by the INNO-LiPA HBV DR line probe assay (version 2). J. Clin. Microbiol. 44: 1994-1997. http://dx.doi.org/10.1128/JCM.02477-05 PMid:16757589    PMCid:1489409 Perz JF, Armstrong GL, Farrington LA, Hutin YJ, et al. (2006). The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J. Hepatol. 45: 529-538. http://dx.doi.org/10.1016/j.jhep.2006.05.013 PMid:16879891 Santantonio T, Fasano M, Durantel S, Barraud L, et al. (2009). Adefovir dipivoxil resistance patterns in patients with lamivudine-resistant chronic hepatitis B. Antivir. Ther. 14: 557-565. PMid:19578241 Tran N, Berne R, Chann R, Gauthier M, et al. (2006). European multicenter evaluation of high-density DNA probe arrays for detection of hepatitis B virus resistance mutations and identification of genotypes. J. Clin. Microbiol. 44: 2792-2800. http://dx.doi.org/10.1128/JCM.00295-06 PMid:16891494    PMCid:1594645 Villet S, Pichoud C, Billioud G, Barraud L, et al. (2008). Impact of hepatitis B virus rtA181V/T mutants on hepatitis B treatment failure. J. Hepatol. 48: 747-755. http://dx.doi.org/10.1016/j.jhep.2008.01.027 PMid:18331765 Wang YZ, Xiao JH, Ruan LH, Zhang HY, et al. (2009). Detection of the rtA181V/T and rtN236T mutations associated with resistance to adefovir dipivoxil using a ligase detection reaction assay. Clin. Chim. Acta 408: 70-74. http://dx.doi.org/10.1016/j.cca.2009.07.016 PMid:19651117 Zhao Y, Zhang XY, Guo JJ, Zeng AZ, et al. (2010). Simultaneous genotyping and quantification of hepatitis B virus for genotypes B and C by real-time PCR assay. J. Clin. Microbiol. 48: 3690-3697. http://dx.doi.org/10.1128/JCM.00741-10 PMid:20720032    PMCid:2953110